4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-23-040333
Options or other derivatives
- Director acquired 1,950,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Magovcevic-Liebisch Ivana · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-22 | Grant or award : show line 1 in the form Stock Option (right to buy) | +1,950,000 | 1,950,000 | D |
Loading xslF345X04/doc4.xml…